We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$74.9B
AUM Growth
-$1.53B
Cap. Flow
-$190M
Cap. Flow %
-0.25%
Top 10 Hldgs %
34.07%
Holding
4,428
New
282
Increased
1,508
Reduced
1,702
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.72%
2 Financials 8.33%
3 Healthcare 6.69%
4 Industrials 4.98%
5 Consumer Staples 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGO icon
4076
Organogenesis Holdings
ORGO
$308M
$143 ﹤0.01%
+33
New +$133
IMNM icon
4077
Immunome
IMNM
$2.52B
$141 ﹤0.01%
+21
New +$201
INDI icon
4078
indie Semiconductor
INDI
$733M
$140 ﹤0.01%
69
-954
-93% -$3.32K
OMER icon
4079
Omeros
OMER
$709M
$140 ﹤0.01%
17
-8,188
-100% -$72.3K
VSTM icon
4080
Verastem
VSTM
$532M
$139 ﹤0.01%
+23
New +$141
ALDX icon
4081
Aldeyra Therapeutics
ALDX
$91.7M
$138 ﹤0.01%
+24
New +$142
PGY icon
4082
Pagaya Technologies
PGY
$1.32B
$136 ﹤0.01%
13
-71
-85% -$788
ERX icon
4083
Direxion Daily Energy Bull 2X ETF
ERX
$249M
$131 ﹤0.01%
2
GYRE icon
4084
Gyre Therapeutics
GYRE
$662M
$131 ﹤0.01%
+17
New +$186
CHGG icon
4085
Chegg
CHGG
$108M
$130 ﹤0.01%
203
-22,042
-99% -$27.3K
CSIQ icon
4086
Canadian Solar
CSIQ
$906M
$130 ﹤0.01%
15
NGNE icon
4087
Neurogene
NGNE
$696M
$129 ﹤0.01%
11
-32
-74% -$556
CMPX icon
4088
Compass Therapeutics
CMPX
$373M
$124 ﹤0.01%
+65
New +$173
ORIC icon
4089
Oric Pharmaceuticals
ORIC
$1.25B
$123 ﹤0.01%
22
-5
-19% -$44
FLNA
4090
Filana Therapeutics
FLNA
$43M
$122 ﹤0.01%
81
-185
-70% -$467
INO icon
4091
Inovio Pharmaceuticals
INO
$79.8M
$116 ﹤0.01%
71
+9
+15% +$18
PDFS icon
4092
PDF Solutions
PDFS
$2.13B
$115 ﹤0.01%
6
-73
-92% -$1.79K
SPRO icon
4093
Spero Therapeutics
SPRO
$68.9M
$109 ﹤0.01%
151
-5,000
-97% -$4.22K
QVCGA
4094
DELISTED
QVC Group Inc Series A
QVCGA
$108 ﹤0.01%
11
-1
-8% -$16
AUTL
4095
Autolus Therapeutics
AUTL
$386M
$99 ﹤0.01%
64
-2,038
-97% -$4.14K
FLWS icon
4096
1-800-Flowers.com
FLWS
$245M
$94 ﹤0.01%
16
FTHM icon
4097
Fathom Holdings
FTHM
$28.2M
$90 ﹤0.01%
102
VUZI icon
4098
Vuzix
VUZI
$190M
$86 ﹤0.01%
+42
New +$138
VGZ icon
4099
Vista Gold
VGZ
$253M
$83 ﹤0.01%
100
INSG icon
4100
Inseego
INSG
$108M
$82 ﹤0.01%
+10
New +$109

Similar funds

US Bancorp's Q1 2025 Portfolio in Review

As of Q1 2025, US Bancorp held 4,428 positions worth $74.9B, down 2% from $76.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

US Bancorp's Q1 2025 filing shows 282 new, 1,508 increased, 1,702 reduced and 242 closed positions. Its largest new stake was Capital Group Dividend Growers ETF: 70,824 shares worth $2.19M. The largest sale was Eli Lilly, an estimated $549M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q1 2025 buy was Capital Group Dividend Growers ETF: 70,824 shares worth $2.19M.
  • US Bancorp added most to Vanguard Total International Stock ETF in Q1 2025, an estimated $460M increase.
  • US Bancorp's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $549M.
  • US Bancorp fully exited Aspen Technology Inc in Q1 2025, selling an estimated $3.17M.
  • US Bancorp's ten largest holdings make up 34% of its $74.9B portfolio in Q1 2025.
  • US Bancorp opened 282 new positions and closed 242 in Q1 2025.
  • US Bancorp's portfolio value fell 2% quarter-over-quarter to $74.9B.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.